Under terms of the technology transfer and license agreement, Eurogentec will convey diagnostic manufacturing technology and provide technical assistance. BD expects to apply this technology to the production of commercial molecular diagnostic kits. Under terms of the supply agreement, Eurogentec will provide molecular diagnostic kit components to BD.
“Eurogentec is extremely pleased to partner with a leading global medical technology company such as BD’’ says Eurogentec CEO Jean-Pierre Delwart, “This is a powerful indicator of increased recognition for Eurogentec’s vision and technical expertise in IVD manufacturing by commercial developers of in vitro diagnostic products. The opening of our GMP/QSR compliant clean room oligonucleotide manufacturing facilities in Europe, North America and Asia was an important strategic decision which, when coupled with our increased integration of IVD and Pharma GMP manufacturing activities, has enabled us to go beyond oligo manufacturing and offer a full range of GMP-grade molecular diagnostic kit components and services. This will further solidify our presence and market share in the rapidly growing North American, Asian and European molecular diagnostics markets.’’
“BD is committed to developing assays and platforms that improve the detection and management of infectious diseases and cancer,” said Philippe Jacon, President, BD Diagnostics – Diagnostic Systems. “Our agreements with Eurogentec reflect this commitment by seeking leading, high-quality technologies and components that help to enhance the capabilities of our products.”
Financial terms of the agreement were not disclosed.
ABOUT EUROGENTEC
Eurogentec S.A. is a leading global supplier of innovative reagents, kits, specialty products and custom services to scientists in the life science, biotechnology, pharmaceutical and diagnostic markets. The Company provides a wide range of expertise in small- and large-scale DNA and RNA manufacturing. Together with its subsidiary Anaspec (Fremont, California) Eurogentec is a leading provider of integrated proteomics solutions for life science research and diagnostics with expertise in peptides synthesis, labelled peptides, antibodies, fluorescent dyes and enzyme activity assays.
Eurogentec S.A. is also an experienced Contract Manufacturing Organization (CMO), operating full-service, state-of-the-art GMP- and ISO13485:2003-certified manufacturing facilities in Belgium that provide high-value custom biologics (including PCR enzymes) and a wide range of oligonucleotide-based components for diagnostic and therapeutic applications.
Eurogentec’s GMP/QSR compliant and ISO13485:2003 certified clean room oligonucleotide manufacturing facility in Belgium is complemented by additional GMP production facilities in North America and Asia.
Eurogentec is a privately held company headquartered in Liège, Belgium, with subsidiaries in France, Germany, the UK, the Netherlands, Switzerland and North America. Eurogentec has additional manufacturing facilities in the United States, Japan and Singapore. Eurogentec employs 375+ people globally.
Please visit www.eurogentec.com for more information.
Contact Dr. Peter Haima Director of Global IVD Services Eurogentec S.A. Liège Science Park Rue Bois Saint-Jean 5 B-4102 Seraing Belgium Tel: +32 4 372 7635 Fax: +32 4 372 7500 Email: p.haima@eurogentec.com PRESS RELEASE PR-BD-0610-EN-V1
